DoW Peer Reviewed Cancer, Clinical Trial Award

This grant supports rapid implementation of clinical trials that could significantly impact cancer treatment or management within FY26 topic areas. It funds trials evaluating new drugs, biologics, devices, clinical guidance, or emerging technologies, ranging from small proof-of-concept studies to large phase III trials, and requires inclusion of patient advocates.